Medicine and Dentistry
Abdominal Aorta
19%
Abdominal Aortic Aneurysm
60%
Acute Coronary Syndrome
33%
Adipocyte
22%
Adipose Tissue
48%
Angiotensin
19%
Angiotensin II
100%
Antiplatelet
26%
Aortic Aneurysm
36%
Biological Marker
30%
Bleeding
31%
Breathing
22%
Cardiac Magnetic Resonance Imaging
65%
Cardiovascular Disease Risk Factor
22%
Clinical Trial
18%
Computer Assisted Tomography
22%
Condom Use
70%
Congestive Heart Failure
71%
Coronary Artery Disease
36%
Curcumin
22%
Diet Induced Obesity
26%
Drug-Eluting Stent
56%
Fibrinolytic Therapy
22%
Glucose Metabolism
23%
Health Outcomes
22%
Heart Function
26%
Heart Ventricle Function
21%
Hyponatremia
22%
Implantable Automatic Defibrillator
23%
Infusion
48%
Left Ventricular Assist Device
33%
Leukocyte
19%
Macrophage
22%
Meta-Analysis
22%
Myocardial Infarction
45%
Odds Ratio
25%
Pacemaker
24%
Placebo
20%
Platelet
41%
Pneumothorax
22%
Primary Percutaneous Coronary Intervention
22%
Public Health
22%
Randomized Controlled Trial
24%
Rosuvastatin
22%
Sexually Transmitted Disease
45%
Sexually Transmitted Infection
22%
ST Segment Elevation Myocardial Infarction
22%
Stent Thrombosis
20%
Systolic Blood Pressure
29%
Tetralogy of Fallot
33%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Aortic Aneurysm
90%
Acetylsalicylic Acid
14%
Acute Coronary Syndrome
22%
Adverse Event
14%
Alzheimer's Disease
22%
Angiotensin
45%
Angiotensin II
91%
Antiplatelet
40%
Aortic Atherosclerosis
13%
Apolipoprotein E
13%
Apolipoprotein E Knockout Mouse
11%
Atherosclerosis
76%
Atrial Fibrillation
44%
Biological Marker
28%
Bleeding
19%
C57BL 6 Mouse
18%
Cardiovascular Disease
24%
Cardiovascular Mortality
11%
Clinical Trial
16%
Clopidogrel
56%
Cohort Study
12%
Congestive Heart Failure
29%
Coronary Artery Disease
36%
Curcumin
11%
Diet Induced Obesity
22%
Digoxin
27%
Dioxins and Dioxin-Like Compounds
11%
Diseases
19%
Heart Infarction
28%
Heart Ventricle Arrhythmia
22%
Hypercholesterolemia
33%
Inflammation
30%
Lipoprotein Lipase
17%
Low Density Lipoprotein Receptor
12%
Mouse Mutant
12%
Normal Human
12%
Pharmacodynamics
22%
Pharmacokinetics
11%
Pharmacovigilance
11%
Placebo
18%
Randomized Controlled Trial
24%
Receptor
38%
Renin
33%
Renin Inhibitor
11%
Sepsis
14%
Sphingosine 1 Phosphate
11%
ST Segment Elevation Myocardial Infarction
33%
Stent Thrombosis
23%
Toxic Injury
12%
Withdrawal Syndrome
12%